Anogenital cancers testing in San Salvatore Monferrato
Find health labs to test for Anogenital cancers in San Salvatore Monferrato and compare all offers by prices and services.
Tests that cover Anogenital cancers
HPV Test
Pap Test by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€65.00
€61.75 with our promocode
See Details
test HPV cavo orale autoprelievo by innovabiohealth S.r.l.
Test at-Home / Self-testing
Featured
€65.00
€61.75 with our promocode
See Details
Pap Smear by Laboratorio Lifebrain
Via del castagnone 28 a, c/o Poliambulatorio Medicart 15048 Valenza (AL)
4.1 km
Pap Smear by Laboratorio Lifebrain
Via Canonico Zuffi c/o Poliambulatorio Valenza Medica 15048 Valenza (AL)
4.1 km
Pap Smear by Laboratorio Lifebrain
Via Bonardi 25, c/o Casa della Salute 15121 Alessandria (AL)
6.1 km
Pap Smear by Laboratorio Lifebrain
Corso Repubblica, 34 15057 Tortona (AL)
15.9 km
Pap Smear by Laboratorio Lifebrain
Via Brigata garibaldi 1 a, c/o Poliambulatorio Medicart 15057 Tortona (Tortona)
15.9 km
Pap Smear by Synlab
Via Giacomo Matteotti, 38, 27058 Voghera PV, Italia
21.6 km
Pap Smear by Laboratorio Lifebrain
Via Salvo D'Acquisto, 108 15011 Acqui Terme (AL)
22.5 km
Pap Smear by Laboratorio Lifebrain
Via Carducci, 13 15076 Ovada (AL)
25 km
Pap Smear by Synlab
Via Roma, 8, 20086 Motta Visconti MI, Italia
29.1 km
Pap Smear by Synlab
Via Gaspare Cavallini, 3, 27100 Pavia PV, Italia
31.8 km
Anogenital cancers - symptoms and how to test
Human papillomavirus (HPV) infection is linked to anogenital malignancies, namely to the alpha genus of mucosal HPV types 16 and 1810,11. There is some evidence that beta-genus HPVs contribute to cutaneous SCC, although it is inconclusive. High-risk HPVs account for 3% of all female malignancies and 2% of all male cancers in the United States. The Centers for Disease Control and Prevention report that each year there are around 45,000 new instances of cancer in areas of the body where HPV is often present. HPV is predicted to cause approximately 36,000 of these (CDC). The HPV test screens for the presence of high-risk HPV strains that are associated with an increased risk of developing cervix precancers and malignancies.
